Author(s): Luo Guijin, Yan Jieying, Chen Yuanbo
Pages: 88-89
Year: 2015 Issue:  5
Journal: China Journal of Pharmaceutical Economics
Keyword:  Maleic acid trimebutine; Oryzanol; Irritable bowel syndrome; The curative effect;
Abstract: Objective To evaluate trimebutine maleate combined with oryzanol in treatment of irritable bowel syndrome efficacy and safety.Methods We selected 50 cases of patients with irritable bowel syndrome,the patients were randomly divided into observation group and control group,each 25 cases,observation combined with oryzanol treated with trimebutine maleate group of patients,the control group was treated with trimebutine maleate in the treatment of patients,treatment effects were compared between the two groups.Results Patients in the observation group treatment is better than the control group,and the adverse reaction is lower than that of the control group,the difference was statistically significant(P < 0.05).Conclusion Trimebutine maleate combined with oryzanol in treatment of irritable bowel syndrome can effectively improve the effect,and high safety.